A SARS-CoV-2 spike-targeting bispecific T-cell engager strategy for controlling SARS-CoV-2 infection
In a recent study published in the Communications Biology Journal, researchers described a novel strategy for controlling severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections where ...
A Yale-designed nasal vaccine can help bolster immune responses to COVID-19 in previously vaccinated animals and reduce viral transmission, Yale researchers report Oct. 27 in the journal Science. The ...
Scientists from Yale University, USA, have recently developed an intranasal spike boosting vaccine that induces robust mucosal immunity in the respiratory tract, in addition to boosting pre-existing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback